Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Dermatology
•
General Dermatology
What is the maximum dose or treatment course of topical steroids that you generally recommend to avoid causing systemic adverse effects?
Answer from: at Community Practice
Topical steroids cause essentially no systemic AEs. Dosing is limited by local AEs.
Sign in or Register to read more
Answer from: at Community Practice
I think you have to be careful with pediatric patients. A mid-potential topical corticosteroid may cause HPA axis suppression in younger skin for two main reasons, wider overall surface area and increased absorption through thinner skin.
Sign in or Register to read more
24922
25374
Related Questions
Have you encountered idiopathic aseptic facial granuloma in areas other than the face?
How frequently do you recommend skin cancer screens in your patients with kidney transplants who are on immunosuppression?
How long can a patient with newly diagnosed merkel cell carcinoma wait for wide local excision with sentinel node biopsy?
What treatment would you offer a patient with extensive lymphangioma circumscriptum intermittently covering the entire abdomen?
What is the role of combination antimicrobial, antiviral, and immunomodulatory therapies in managing recurrent erythema multiforme with suspected infectious triggers?
What is your preferred workup for a patient who has a biopsy consistent with “dermal hypersensitivity reaction”?
In the era of targeted therapies, are there any specific cytokines that help guide therapy?
What laboratory workup do you perform in patients with symptoms consistent with erythromelalgia?
Would you recommend continuing Accutane in a teenage female who has experienced a drop in calcium to 8.8 and reductions in albumin and protein levels one month into therapy?
How would you approach JAK inhibitors in pregnancy?